Long-Term Neurologic Problems Rise by 7% After SARS-CoV-2 Infection
Risk of movement disorders, memory problems, strokes, and seizures rose 1 year after acute SARS-CoV-2 infection, an analysis of millions of U.S. veterans’ records showed. Former COVID patients had a 42% increased risk of neurologic problems 12 months after testing positive (HR 1.42, 95% CI 1.38-1.47), reported Ziyad Al-Aly, MD, of Washington University in St. […]
Rare Seizure Disorder Gets Its First Drug Approval
Ganaxolone (Ztalmy) won approval to treat seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD), a rare genetic epilepsy, in patients ages 2 and older, the FDA announced. Ganaxolone is a neuroactive steroid that acts as a positive allosteric modulator of the GABAA receptor. The oral therapy is the first drug approved specifically for […]